Payden & Rygel’s Hologic HOLX Stock Holding History

Payden & Rygel’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-257	Closed	-$10K	–	183
2015 Q4	$10K	Buy	+257	New	+$10K	﹤0.01%	182

Other funds holding HOLX

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCM

Tran Capital Management San Rafael, California $869M AUM 52.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Payden & Rygel's HOLX Position: Q1 2016 in Review

Payden & Rygel sold out of Hologic (HOLX) in Q1 2016, closing a stake of 257 shares — an estimated $10K sold.

Payden & Rygel first reported a position in HOLX in Q4 2015 and held it in 1 quarter. The position peaked at $10K in Q4 2015. 456 funds tracked by Wall St. Rank hold HOLX as of Q1 2016.

Payden & Rygel reported no remaining Hologic position as of Q1 2016 after selling out during the quarter.
Payden & Rygel sold 257 Hologic shares in Q1 2016, an estimated $10K.
Payden & Rygel first reported a position in Hologic in Q4 2015 and held it in 1 quarter.
Payden & Rygel's Hologic position peaked at $10K in Q4 2015.
456 funds tracked by Wall St. Rank held Hologic as of Q1 2016.

Based on Payden & Rygel's 13F filing for Q1 2016, filed 6 May 2016.